All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

8

Reset

8 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • CorabotaseIPN10200Phase 37 trials

    Ipsen · Moderate to Severe Glabellar Lines, Spasticity, Moderate to Severe Upper Facial Lines

  • BR005-036CPhase 32 trials

    Brise Pharmaceuticals Co., Ltd. · Migraine, With or Without Aura

  • AXS-07meloxicam-rizatriptanPhase 31 trial

    Axsome Therapeutics, Inc. · Migraine

  • EVO756Phase 24 trials

    Evommune, Inc. · Migraine, Chronic Inducible Urticaria, Atopic Dermatitis

  • BHV-2100Phase 21 trial

    Biohaven Therapeutics Ltd. · Migraine

  • MEDI0618Phase 21 trial

    AbbVie · Migraine

  • MTX101Phase 21 trial

    Manistee Therapeutics · Migraine

  • PRT-064040Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.